Mark Ware, MBBS, MRCP, M.Sc. - Mark Ware, MBBS, MRCP, M.Sc. - Research Institute MUHC
pain • cannabinoids • neuropathy • epidemiology • pharmacovigilance
My research focuses on the evaluation of the safety, efficacy and effectiveness of novel patient-centred approaches to chronic pain management. My team conducts clinical trials and long term studies of the use of cannabis and cannabinoid medications, and we are involved in efforts to translate these findings into medical education for health professionals, and to evaluate the effectiveness of these learning approaches.
Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet JP. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010 Oct 5;182(14):E694-701. doi: 10.1503/cmaj.091414. Epub 2010 Aug 30. PMID: 20805210.
Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010 Feb 1;110(2):604-10. doi: 10.1213/ANE.0b013e3181c76f70. Epub 2009 Dec 10. PMID: 20007734.
Ware MA, Bennett GJ. Case report: Long-standing complex regional pain syndrome relieved by a cephalosporin antibiotic. Pain. 2014 Jul;155(7):1412-5. doi: 10.1016/j.pain.2014.03.014. Epub 2014 Mar 22. PMID: 24667741.
Ware MA, Ziemianski D. Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities. Clin Pharmacol Ther. 2015 Jun;97(6):548-50. doi: 10.1002/cpt.103. PMID: 25728558.
Moulin DE, Clark AJ, Gordon A, Lynch M, Morley-Forster PK, Nathan H, Smyth C, Toth C, VanDenKerkhof E, Gilani A, Ware MA. Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study. J Pain. 2015 Sep;16(9):852-61. doi: 10.1016/j.jpain.2015.05.011. Epub 2015 Jun 12. PMID: 26080044.